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Should Ablative Operations Be Used for Bleeding
Esophageal Varices?
BLAIR A. KEAGY, M.D. JOHN A. SCHWARTZ, M.D. GEORGE JOHNSON, JR., M.D.
To evaluate the long-term success of an ablative procedure for
esophageal varices, the clinical results of 60 standardized, non-
shunt (Womack) operations performed from 1953-1974 were
reviewed. The overall operative mortality in this series was 35%.
The 39 patients surviving operation have been followed from 5
to 21 years (mean: 13.3 years). Excluding operative mortality,
the absolute 5-year survival rates for Child's classes A, B, and
C patients were 100%, 63%, and 33%, respectively. The actuarial
survival for all patients was 40% at 5 years, 24% at 10 years,
and 15% at 15 years. Although the incidence of recurrent bleeding
was 54%, clinical factors predictive for rebleeding could not be
identified. A review of a collected series of other ablative oper-
ations, with and without esophageal tansection, generally reveals
unacceptable mortality and rebleeding rates. It is concluded that
an ablative operation without esophageal transection should be
used only in highly selected patients who do not have appropriate
veins suitable for venous shunt.
G UIDO BANTI, a young, Italian physician at the
Institute of Pathologic Anatomy in Florence,
first proposed splenectomy for "splenic anemia"
in a paper published in 1883.1,2 His original concept was
perpetuated and formed the basis for many subsequent
variations on an ablative operation for bleeding esophageal
varices secondary to portal hypertension. In this country,
splenectomy for "splenic anemia" became popular in the
early part of the century owing primarily to its support
by prominent physicians including Sir William Osler3 and
William Mayo.2'4 Splenectomy remained popular until
1945, when Pemberton5 ofthe Mayo Clinic reviewed their
results. He reported recurrent bleeding after splenectomy
in 30% of patients who were operated on for a history of
hemorrhagic complications (gastrointestinal bleeding or
unspecified sites).
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Phemister and Humphries6 ofChicago presented a pa-
per before the American Surgical Association in 1947 on
esophagogastrectomy for bleeding esophageal varices due
to portal hypertension. Nathan Womack, then of Barnes
Hospital in St. Louis, was in the audience and was in-
trigued by an operation that was apparently able to control
variceal hemorrhage without causing encephalopathy and
without diverting flow from the liver. He was impressed
that this was a more physiologic procedure than the shunt
operation being proposed at the time.7 While at the Uni-
versity of Iowa, Womack devised an ablative operation
to treat bleeding esophageal varices, which he later im-
plemented at the University of North Carolina at Chapel
Hill. His procedure was designed to control the hyperdy-
namic portal and systemic circulatory state that occurred
in these patients.8'9
During the last several decades, there has been renewed
interest in variations on ablative operations to control
bleeding esophageal varices. Numerous procedures have
been described, and their various results published in the
literature. The present report reviews the clinical results
and long-term follow-up of one standardized form of
nonshunt operation, that proposed by Dr. Womack,'° in
60 patients operated on at the University of North Car-
olina from March 1953 through May 1974.
Patients and Methods
Sixty adult patients with a history of upper gastroin-
testinal bleeding comprise this series. All patients were
thought to have had bleeding from esophageal varices and
portal hypertension due to hepatic cirrhosis. Endoscopic
documentation of variceal hemorrhage was not routinely
employed. Patients less than 21 years of age and others
with noncirrhotic portal hypertension were excluded from
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TABLE 1. Comparison ofResults Following the "Womack" Procedure
Operative No. 5-Year
Patient Mortality Surviving Absolute
Population No. Rate Operation Survival
Total 60 35% 39 62%
Child's class A 8 0% 8 100%
Child's class B 25 24% 19 63%
Child's class C 27 56% 12 33%
Alcoholic 38 32% 26 62%
Nonalcoholic 22 41% 13 62%
Elective 29 28%
Emergency 31 42%
the analysis. Demographic information and pertinent
clinical data, such as assessment of hepatic function and
hemodynamic parameters, were collected and stored on
an IBM 1130 computer (Armonk, NY) for retrieval and
subsequent analysis. Cardiac output using cardiogreen dye
dilution and blood volume by radioactive iodinated al-
bumin were determined before operation in patients who
underwent elective operation to evaluate the hyperdyn-
amic circulatory state associated with cirrhosis. These
methods9 and their results" have been described previ-
ously.
The operation performed on all 60 patients consisted
ofsplenectomy, resection ofthe superior halfofthe greater
curvature ofthe stomach, ligation and division of all ves-
sels along the lesser curvature from the inferior one-third
to the diaphragm, and transgastric oversewing of the var-
ices. In 54 patients, a liver biopsy was obtained at the time
of operation. Occasionally, a gastrostomy was also per-
formed. The spleen was weighed after removal in 49 of
the patients.
The basic procedure described above represented the
only form of operative therapy offered to patients with
bleeding esophageal varices due to portal hypertension at
the North Carolina Memorial Hospital until 1971. Con-
sequently, there were no additional selection criteria ap-
plied to the first 55 consecutive patients in this series,
other than the fact that they were considered surgical can-
didates. The last five ablative operations were performed
during a period when shunt operations were also utilized.
The follow-up data to be reported include survival, in-
cidence of rebleeding, and encephalopathy. These data
were analyzed by absolute and actuarial survival (Kaplan-
Meier"2). In the actuarial analysis, patients were with-
drawn alive at the time of another procedure to control
recurrent variceal bleeding. Operative mortality was de-
fined as death during the same hospitalization as surgery
or within 30 days of operation. Chi square analysis was
used to evaluate the difference in results based on clinically
obtained data. All patients surviving the operation were
followed for a minimum of 5 years and as long as 21
years; mean length of follow-up was 13.3 years.
Results
There were 37 males and 23 females whose ages ranged
from 21 to 73 years (mean: 51.5 years). The distribution
of these patients by Child's classification of liver disease
was A in eight, B in 25, and C in 27 patients. Thirty-eight
patients (63%) were thought to have liver disease as a result
of alcohol abuse, and 22 patients (37%) had disease sec-
ondary to other causes. Twenty-nine procedures (48%)
were performed electively; the remaining 31 operations
(52%) were performed as an emergency for uncontrollable
gastrointestinal hemorrhage. Liver biopsies that were ob-
tained in 90% of the patients were all consistent with cir-
rhosis.
The overall operative mortality rate was 35% (21/60
patients). The operative mortality and absolute 5-year
survival, with respect to the preoperative severity of liver
disease, etiology of portal hypertension, and indication
for operation, are summarized in Table 1. None of the
class A patients with evidence ofadequate hepatic reserves
died as a result of operation. The operative mortality rate
in class A patients (0%) was not statistically different from
that of class B patients (24%). The operative mortality
rate in class C patients (56%) was significantly higher than
that of both class A (p = 0.005) and class B (p = 0.02)
patients. There was no difference in early postoperative
mortality in the alcoholic patients (32%) compared to
nonalcoholics (41%). The operative mortality for elective
procedures (28%) was no different from that ofemergency
operations (42%), p = 0.47. No relationship between op-
erative mortality and age, sex, platelet count, spleen
weight, preoperative cardiac output, or preoperative blood
volume could be identified.
The overall absolute survival at 5 years was 40% (24/
60). Of the 39 patients surviving operation, the absolute
survival was 62% (24/39) at 5 years (Table 1). Absolute
5-year survival rates according to Child's classification
were class A-100%, class B-63%, and class C-33%.
Survival at 5 years was significantly improved for class A
patients compared to class B (p = 0.04) and class C (p
= 0.003) patients. Identical late survival rates were noted
for alcoholic and nonalcoholic patients, 62% at 5 years.
The actuarial survival of all 60 patients was 40% at 5
years, 24% at 10 years, and 15% at 15 years (Fig. 1). Four
patients had subsequent operations and were withdrawn
alive, two at 9 months and one each at 15 and 49 months.
The incidence of rebleeding in the 39 patients surviving
operation was 54% (Table 2). The incidence of rebleeding
in patients with portal hypertension secondary to alcohol
abuse was the same as that noted in patients with non-
alcoholic cirrhosis. Of the patients whose spleen weights
were recorded at the time of operation, 33 survived. The
incidence of recurrent bleeding was 67% in 26 patients
with spleen weights greater than 800 g, compared to a
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33% incidence in 9 patients whose spleen weighed 800 g
or less; this difference did not achieve statistical signifi-
cance (p = 0.08). No preoperative clinical factor (i.e., age,
sex, platelet count, cardiac output, or blood volume) was
predictive of recurrent bleeding from varices in the late
postoperative period. There were no cases of hepatic en-
cephalopathy in the postoperative period that could be
related to the operation performed.
Discussion
Management of bleeding from esophageal varices con-
tinues to be a major challenge. Many operations intended
to "ablate," "disconnect," or "decongest" the dilated ve-
nous collaterals of the esophagus and stomach have been
devised. The results achieved with a variety of these pro-
cedures continue to be compiled and reported in the lit-
erature. 3
The selection of therapy for bleeding esophageal varices
remains controversial. For several reasons, the present re-
port represents a unique experience with an ablative op-
eration for portal hypertension. (1) It was the only type
of operation performed for bleeding esophageal varices
in our institution during the initial 18 years of this study.
Therefore, selection bias, in terms of a shunt versus a
nonshunt procedure, was completely absent in 55 patients,
92% of the total series. (2) The basic operative technique
was uniform for all patients. (3) Long-term results are
available, with all patients being followed at least 5 years
and others for as long as 21 years. However, this report
suffers from the lack ofa comparable group prospectively
treated by medical therapy or an alternative surgical pro-
cedure.
Two basic problems persist with respect to ablative op-
erations for bleeding esophageal varices. The first relates
to the operative mortality rate of nonshunt procedures in
patients from the United States who often have alcoholic
cirrhosis. The operative mortality in our series was quite
high, 35%. Although the majority of our patients (62%)
were at increased risk for death, having either advanced
liver disease (Child's class C) or emergency operation for
uncontrolled bleeding, the 24% mortality rate in the re-
maining class A and B patients operated upon electively
was still appreciable.
The second problem associated with nonshunt opera-
tions concerns the control of bleeding. The 54% incidence
of rebleeding noted in our series is unacceptable for an
operation designed to control bleeding from esophageal
varices. This incidence is higher than what we have pre-
viously reported" with the "Womack" procedure. It is
also greater than that seen with lesser procedures, such as
splenectomy alone5 or transesophageal ligation of varices
without devascularization." Although it was thought that
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FIG. 1. Actuarial survival of 60 patients treated for bleeding esophageal
varices by the Womack procedure.
the initial gastrointestinal bleeding and possibly relate to
the incidence of rebleeding, this was not supported by our
data. It is ofconcern whether any ablative operation could
ever effectively control bleeding from a collateral circu-
lation in which high pressures persist; recurrent or new
varices would eventually form and lead to further
bleeding.
The similarity in survival between the alcoholic and
nonalcoholic patients in our series conflicts with the find-
ings ofZeppa'4 and Warren,'5'16 who have reported poorer
survival in alcoholic patients after selective, distal sple-
norenal shunts. It was anticipated that the "Womack"
procedure would produce results somewhat similar to
those seen with selective shunt operations, since both pro-
cedures preserve portal flow to the liver. Our observation
of equivalent clinical results in alcoholics and in patients
with other causes ofportal hypertension is more consistent
with the pattern of survival reported in series of patients
after nonselective shunting procedures. This finding may
be related to the fact that if our patients survived the op-
eration they apparently stopped drinking.
In order to compare our results to the variety of other
"ablative" procedures currently performed, it is conve-
nient to classify the procedures into three basic types:
esophageal transection and reanastomosis, gastroesoph-
ageal devascularization without esophageal transection,
and gastroesophageal devascularization with esophageal
transection (Table 3).
TABLE 2. Incidence ofRebleeding Following the "Womack" Procedure





Spleen weight 2 800 grams 9 33%
Spleen weight < 800 grams 24 67%
Platelets > 100,000 14 57%
Platelets < 100,000 16 56%
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TABLE 3. Collected Series of "Ablative" Operations
No. of Operative Length of Incidence
Author, Year Patients Mortality Follow-up Rebleeding
Esophageal transection alone
Linschoten,'8 1982 64 39%
Wanamaker,'9 1983 20 60% avg 31 mo 50%
Gouge,20 1986 15 53% to 35 mo 27%
Ablation without transection
Hassab,21 1970 605 10% to 12.5 yr 7%
Skinner,22 1969 3 0% to 2 yr 0%
Estes,23 1984 12 17% to 7.5 yr 20%
Present report, 1985 60 35% avg 13.5 yr 54%
Ablation with transaction
Ginsberg,24 1982 20 20% to 50 mo 0%
Sugiura,25 1984 636 5.2% to 15 yr 6%
Giodani,26 1985 64 11% to 9 yr 6.5%
Johnston,27 1982 80 14% avg 3 yr 20%
Weese,28 1984 11 36% to 28 mo 14%
Gouge,20 1986 21 9.5% to 52 mo 37%
Esophageal transection and reanastomosis has been
performed using the button of Boerema,'8 the EEA sta-
pler (U.S. Surgical Corp., Norwalk, CT),'8"9 or sutures.20
Included in this category are the results reported by
Gouge20 using a suture technique of transthoracic esoph-
ageal transection and reanastamosis. Table 1 summarizes
his results with this procedure alone in 15 patients sepa-
rately from a group of 21 patients undergoing transection
combined with a more complete thoracic and abdominal
devascularization, which will be discussed in a later sec-
tion. In general, esophageal transection and reanastomosis
procedures are associated with high mortality and re-
bleeding rates. The results achieved with these techniques
are similar to those following transthoracic, intraesopha-
geal ligation of varices proposed by Linton."7 Since these
series usually contain high-risk patients, the high operative
mortality rates might be anticipated. However, the re-
ported rates of rebleeding are again excessive and are cer-
tainly unacceptable for a definitive procedure.
There are several available reports ofablative operations
without esophageal transection. In Hassab's series2' from
Egypt, a large number of procedures were performed for
portal hypertension and bleeding esophageal varices with
very acceptable results; however, the etiology of liver dis-
ease in the majority of his patients was schistosomiasis.
It is difficult to compare the results ofan ablative operation
in his patients with parasitic infestation to those in patients
seen in the United States, who usually develop liver disease
secondary to alcoholism or hepatitis. Skinner22 proposed
an extensive paraesophageal devascularization but added
methodical oversewing of the varices. He has reported
good initial results, but only in a very limited number of
patients. The series reported by Estes,23 as well as the
present report, suggests that an ablative operation without
a procedure to completely disconnect the mucosal, sub-
mucosal, and extrinsic venous system of the esophagus
does not control recurrent bleeding.
The final type of procedure consists of ablative oper-
ation along with esophageal transection and reanasto-
mosis. Ginsberg24 has reported excellent results in a very
highly selected group ofpatients with this type ofoperation
using the EEA stapler. His procedure is designed to pre-
serve "the acquired portosystemic shunts, including those
in the periesophageal plexus," while interrupting the in-
traesophageal venous plexus by transection. Sugiura's
group in Japan continues to report outstanding clinical
results.25 However, 185 of the 636 patients reported in
his extensive series had no history ofupper gastrointestinal
bleeding and were operated on prophylactically. Although
it is impossible to separate the prophylactic procedures
from his reported data, even if all operative mortalities
and episodes of rebleeding followed the 451 therapeutic
operations, exceptional results would still be obtained.
Sugiura is credited with emphasizing the importance of
maintaining the connection of the coronary-azygos col-
lateral venous circulation to effectively decrease the in-
cidence of rebleeding. In contrast, Giordani26 has also re-
ported good results with a complete portoazygos discon-
nection, in addition to esophageal transection, using either
the button of Boerema or the EEA. However, very few
patients (7.8%) in his series were class C, and only 80%
of the patients were followed long-term, with a limited
mean follow-up of 33 months. Johnston27 has docu-
mented moderate rates for both operative mortality and
rebleeding utilizing the EEA instrument along with sub-
diaphragmatic devascularization in a series of patients
unfit for shunt surgery. Weese28 has reported a high op-
erative mortality rate for esophageal transection and
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reanastomosis, using the EEA, in a small series of 11 pa-
tients, yet the incidence ofrebleeding was reasonably low.
Gouge20 has reported a high incidence of rebleeding in
his group of patients undergoing both the thoracic and
abdominal procedures; however, the coronary vein was
ligated, disconnecting the portoazygos collateral system
in these patients.
It is apparent that attempts by surgeons in this country
to duplicate the clinical results achieved by others using
various ablative operations, having different concepts of
pathophysiology, in different patient populations, have
been met with only limited success.
In contrast to the results of ablative operations reviewed
above, the long-term results currently being reported from
several centers in North America with selective transsple-
nic decompression of esophageal varices, or the spleno-
renal shunt, are encouraging. The immediate postoper-
ative mortality rate in the well-prepared patient is low,
and the incidence ofshunt occlusion and encephalopathy
is acceptable, approximately 10%.29 Similar results, at least
in terms of mortality and shunt patency, have also been
reported for total shunts such as the portacaval shunt.29
In summary, our results, as well as those reported from
various other series in the United States, have shown
ablative operations for bleeding esophageal varices in the
adult age group to be associated with a prohibitive risk of
operative mortality and recurrent gastrointestinal bleed-
ing. It is concluded that in this situation ablative proce-
dures should only be used in highly selected patients who
cannot undergo a decompressive shunt. If an operation
is indicated and appropriate veins are available, some type
of portal venous decompression is preferred in patients
with bleeding esophageal varices. Although surgeons
seeing a limited number ofthese patients may find ablative
operations technically easier to perform, this fact alone
does not justify the use of a nonshunt procedure in an
individual with suitable venous anatomy. To clearly define
the effect of the addition ofesophageal transection on the
clinical results achieved with ablative procedures, larger
numbers of patients and longer follow-up intervals will
be required. For the present, these procedures should be
evaluated only in interested centers that have adequate
resources and the technical expertise necessary to manage
these challenging patients.
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